CRM
ELV icon

Cramer Rosenthal McGlynn’s Elevance Health ELV Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-84,934
Closed -$20.4M – 112
2019
Q3 		$20.4M Sell
84,934
-49,630
-37% -$13.6M 0.58% 68
2019
Q2 		$38M Sell
134,564
-50,809
-27% -$13.9M 1.04% 35
2019
Q1 		$53.2M Buy
185,373
+55,984
+43% +$16.2M 1.27% 28
2018
Q4 		$34M Buy
129,389
+102,549
+382% +$28.2M 0.86% 47
2018
Q3 		$7.36M Sell
26,840
-3,884
-13% -$1.01M 0.14% 119
2018
Q2 		$7.31M Sell
30,724
-10,966
-26% -$2.54M 0.13% 120
2018
Q1 		$9.16M Buy
+41,690
New +$9.79M 0.15% 127

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Cramer Rosenthal McGlynn's ELV Position: Q4 2019 in Review

Cramer Rosenthal McGlynn sold out of Elevance Health (ELV) in Q4 2019, closing a stake of 84,934 shares — an estimated $20.4M sold.

Cramer Rosenthal McGlynn first reported a position in ELV in Q1 2018 and held it in 7 quarters. The position peaked at $53.2M in Q1 2019. 1,110 funds tracked by Wall St. Rank hold ELV as of Q4 2019.

  • Cramer Rosenthal McGlynn reported no remaining Elevance Health position as of Q4 2019 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 84,934 Elevance Health shares in Q4 2019, an estimated $20.4M.
  • Cramer Rosenthal McGlynn first reported a position in Elevance Health in Q1 2018 and held it in 7 quarters.
  • Cramer Rosenthal McGlynn's Elevance Health position peaked at $53.2M in Q1 2019.
  • 1,110 funds tracked by Wall St. Rank held Elevance Health as of Q4 2019.

Based on Cramer Rosenthal McGlynn's 13F filing for Q4 2019, filed 13 Feb 2020.